By now everyone knows that virtual care usage exploded over the last year, forging a new competitive era of telehealth. While more choice and greater access are generally good things for consumers in any industry (and this is also true for healthcare where patients, our “consumers,” have historically had neither) the growing virtual care market also has the potential to lead to a more fragmented ...
Direct-to-consumer virtual care company Hims & Hers Health is looking to expand its skincare services, and has announced plans to buy teledermatology platform Apostrophe for an undisclosed sum.
This comes just weeks after the company revealed that it was acquiring British telehealth company Honest Health with an eye to continue its U.K. expansion and enter the E.U. market.
Apostrophe...
Direct-to-consumer telehealth company Hims & Hers is looking to go global with its new acquisition of British personalized health company Honest Health for an undisclosed sum.
Founded in 2018, Honest Health specializes in providing hair-loss-related products to customers and currently has an exclusive relationship set up with a U.K. compounding pharmacy and fulfillment center. Like Hims...
Consumer telehealth and wellness brand Hims & Hers came out on top of its projections for the first quarter of 2021, according to its financial results report released today.
In its report from Q4 2020, Hims & Hers estimated its revenue to total between $48 million and $50 million, while adjusted EBITDA was expected to land within -$9.5 million and -$11.5 million.
“Building on our...
Shares of consumer-friendly telehealth and wellness company Hims & Hers took a hit late last week when the company pulled back the curtain on its first quarterly earnings since going public through a special purpose acquisition company (SPAC) merger.
While the company posted 2020 revenue that beat market expectations, its roughly $16 trading price immediately dipped from about $16 to the $14...
Consumer telehealth and wellness brand Hims & Hers wrapped up its merger with special purpose acquisition company (SPAC) Oaktree Acquisition Tuesday, and today began trading on the New York Stock Exchange.
The deal was first announced in October, and was originally expected to close before the end of its Q4 2020. After Tuesday's approval, the deal has provided Hims with $279.5 million, $205...
As Hims & Hers prepares for the public market, it’s adding new members to its board with backgrounds in investing and consumer tech. This morning it exclusively announced to MobiHealthNews two new board members Lynne Chou O’Keefeand David Wells.
O’Keefe comes from an investment background. She is the founder and managing partner of Define Ventures and served as a partner in the Life Sciences...
Digital pharmacy Hims & Hers has reported 91% year-over-year growth during the third quarter of this year.
This comes just weeks after the company announced a merger agreement with Oaktree Capital Management-sponsored special purpose acquisition company (SPAC) Oaktree Acquisition. The public can expect the reverse merger to close at the end of the fourth quarter of 2020.
Hims made a name...
Consumer-friendly telehealth and mail-order wellness product service Hims is officially entering the public markets. Today it announced a merger agreement with Oaktree Capital Management-sponsored special purpose acquisition company (SPAC) Oaktree Acquisition Corp.
The reverse merger is expected to close in the fourth quarter of 2020, and places the combined entity at a roughly $1.6 billion...
About the authors: Andrew Dudum is the CEO and founder of Hims & Hers, a consumer-facing digital health company offering telehealth services.
Joel White is executive director of the Health Innovation Alliance, a coalition of health and technology leaders who support policies that use technology and data to make healthcare work better.
Outside of these positions, Dudum and White report no...
 _6.JPG?itok=njpLIcCn)
_8.jpg?itok=WyEcRi5G)
